News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
TradingKey Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
ARK Investment Management LLC and its CEO/CIO, Catherine D. Wood, have reported a beneficial ownership of 2,027,920 shares of 908 Devices Inc. common stock, which represents 5.32% of the outstanding class. The disclosure, filed as a Schedule 13G/A, indicates that ARK has sole voting …
908 Devices (MASS) saw its stock price remain largely flat despite reporting a strong quarter in handheld revenue growth. While revenue increased and the adjusted EBITDA loss narrowed, concerns persist regarding the company's path to sustained profitability, heavy government exposure, and the lower margins …
Massimo Group (MAMO) reported a profit for the first half of 2026, reaching $0.44 million, a significant improvement from a $2.0 million loss in the prior-year period. This turnaround occurred despite a 21.1% decline in quarterly revenue to $14.9 million, primarily due to weaker …
Stifel raised its price target for 908 Devices Inc. (NASDAQ:MASS) to $12.00 from $10.00, maintaining a Buy rating, following the company's strong second-quarter performance and revised full-year guidance. The analyst noted positive business momentum, expanding adoption opportunities, and an expected 23% revenue growth in …
908 Devices Inc. (MASS) reported strong Q2 2026 results with a 23% revenue increase to $16.1 million, driven by demand from US state and local customers. The company significantly improved profitability, cutting adjusted EBITDA loss by over 50% year-over-year, and raised its full-year 2026 …
908 Devices Director Christopher Brown sold 8,358 shares of the company's stock for $77,144, reducing his ownership by 1.03%. This sale occurred under a pre-arranged Rule 10b5-1 plan. The company recently reported better-than-expected quarterly revenue and adjusted EPS, and raised the lower end of …
908 Devices Inc. director Christopher D. Brown sold a total of 17,800 shares of common stock in two open-market transactions on August 10 and August 11, 2026. These sales, executed under a Rule 10b5-1 trading plan adopted in November 2025, involved weighted average prices …
Kevin J. Knopp, President and CEO of 908 Devices Inc. (MASS), reported selling 149,013 shares of common stock between August 10 and 12, 2026, under a Rule 10b5-1 trading plan. The sales occurred at weighted average prices ranging from $9.06 to $10.16 per share. …
908 Devices Inc. announced that its CEO and CFO will present at the 17th Annual Midwest IDEAS Conference on August 26, 2026. The company, which specializes in handheld chemical analysis tools, will host investor meetings and webcast its presentation. This event provides an opportunity …
908 Devices Inc. (MASS) reported strong Q2 2026 results with a 23% revenue increase to $16.1 million, driven by demand from US state and local customers. The company significantly improved profitability, cutting adjusted EBITDA loss by over 50% year-over-year, and raised its full-year 2026 …
908 Devices Inc. (NASDAQ: MASS) reported a wider-than-expected Q2 2026 loss of $0.32 per share, missing consensus estimates of a $0.17 loss, despite revenue growing 23.0% year-over-year to $16.1M. The company's net loss was $11.9M due to investments in commercial infrastructure and product development, …
908 Devices Inc. reported a 23% year-over-year revenue growth in Q2 2026, exceeding Wall Street expectations, with revenue reaching $16.1 million. The company is nearing profitability, with management raising full-year 2026 revenue guidance to $68 million-$70 million and projecting positive adjusted EBITDA of $0.7 …
908 Devices Inc. (MASS) reported a Q2 loss of $0.11 per share, outperforming the Zacks Consensus Estimate of a $0.14 loss, and marking a +21.43% earnings surprise. The company's revenues reached $16.07 million, surpassing estimates by 5.92% and showing growth from $13.03 million a …
908 Devices Inc. (MASS) reported a strong Q2 2026 with revenue up 23% year-over-year to $16.1 million, driven by VipIR product demand and NIRLab contributions. The company also raised the low end of its full-year 2026 revenue guidance to $68.0–$70.0 million, representing 21%–25% growth …
908 Devices (NASDAQ: MASS) reported Q2 2026 revenue of $16.1 million, a 23% increase year-over-year, with its adjusted EBITDA loss significantly narrowing to $1.9 million. This improvement was driven by product sales growth and the NIRLab acquisition. Despite positive operational momentum and a strong …
908 Devices Inc. reported Q2 2026 results with revenue of $16.07 million, a 23.3% increase year-over-year, and a narrowed net loss of ($11.89 million). Diluted loss per share improved to ($0.32) from ($0.37) in the prior-year quarter. Revenue growth was driven by higher device …
908 Devices Inc. reported strong second-quarter 2026 financial results, with revenue increasing 23% year-over-year to $16.1 million and Adjusted EBITDA loss more than halved. The company also raised the low end of its full-year 2026 revenue outlook to $68.0 million, reflecting 21% to 25% …
908 Devices Inc. (Nasdaq: MASS) reported strong second-quarter 2026 financial results, with revenue increasing 23% year-over-year to $16.1 million and adjusted EBITDA loss narrowing by more than half. The company secured a $6 million ProtectIR order from an Asia-Pacific corrections agency and raised the …
Christopher Brown, an investor in MASS, has filed a Form 144 to sell 100,000 shares of MASS common stock, valued at $888,000.00. These shares were originally acquired as founder's shares and will be sold through Morgan Stanley Smith Barney LLC. The filing also notes …
This document is a statement of changes in beneficial ownership of securities for Director Christopher D. Brown of 908 Devices. It reports transactions related to his holdings in the company.
908 Devices (NASDAQ:MASS) Director Christopher Brown sold 20,000 shares of the company's stock on August 5th for $169,800. This transaction, executed under a pre-arranged Rule 10b5-1 trading plan, reduced his ownership by 2.37% to 823,359 shares. The stock is currently trading at $8.88, near …
This article provides an earnings forecast for 908 Devices Inc. (MASS), highlighting its strong earnings forecast score of 9.20 within the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $10.00, with a consensus "Strong Buy" rating based on 5 …
Christopher D. Brown, a director at 908 Devices Inc. (MASS), sold 20,000 shares of common stock on August 5, 2026, at a weighted average price of $8.49 per share. This transaction was executed under a Rule 10b5-1 trading plan adopted on November 24, 2025. …
AWM Investment Company, Inc., a ten percent owner of 908 Devices Inc. (MASS), indirectly sold 50,000 shares of Common Stock on August 4, 2026, at a weighted average price of $8.3553 per share. Following this transaction, AWM's aggregate holdings through advised limited partnerships amount …
This article provides a financial forecast for Massimo Group (MAMO), focusing on future EPS and revenue growth estimates. It includes an overview of the company's current stock price, market capitalization, and P/E ratio, along with a peer comparison in the Automobiles & Auto Parts …
908 Devices is scheduled to report its financial results pre-market on August 11. This earnings preview provides investors with key information regarding the upcoming announcement, which is crucial for assessing the company's financial health and future prospects.
Search by ticker symbol or company name and select a result to open its chart.